The CAM1615HER2 TriKE also demonstrated activity against a broad panel of HER2-expressing tumors including pancreatic (BxPC-3), prostate (C4-2), lung (NCI-H322), and breast (MCF-7L) cancer (Supplementary Figure S4). The gene discussed is ERBB2; the disease is cancer.